| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/26/2003 | EP1284974A2 Triazolyl tropane derivatives as ccr5 modulators |
| 02/26/2003 | EP1284973A2 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 02/26/2003 | EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 02/26/2003 | EP1284956A1 Il-8 receptor antagonists |
| 02/26/2003 | EP1284752A1 Bispecific molecules and uses thereof |
| 02/26/2003 | EP1284747A2 Compositions and methods for achieving immune suppression |
| 02/26/2003 | EP1284743A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 02/26/2003 | EP1284741A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 02/26/2003 | EP1284740A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono- and disaccharide-based compounds |
| 02/26/2003 | EP1284737A1 Water soluble prodrugs of azole compounds |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 02/26/2003 | EP1284721A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 02/26/2003 | EP1284720A2 Method of treating hepatitis delta viral infection |
| 02/26/2003 | EP1186654A4 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 narine aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof |
| 02/26/2003 | EP1119539B1 A process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds |
| 02/26/2003 | EP1042324B1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |
| 02/26/2003 | EP0929571B1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 02/26/2003 | EP0850059B1 Pharmaceutical formulations containing darifenacin |
| 02/26/2003 | EP0824535B1 Antibacterial cephalosporins |
| 02/26/2003 | EP0770137B1 Improvements in production of proteins in host cells |
| 02/26/2003 | EP0768893B1 Polynucleotide vaccine for papillomavirus |
| 02/26/2003 | EP0708763B1 Process for making hiv protease inhibitors |
| 02/26/2003 | CN1399679A Altering gene expression with ssDNA produced in vivo |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399642A Method of preparing clarithromycin |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/26/2003 | CN1399627A Method of preparing substituted tetracyclines with transition metal-based chemistries |
| 02/26/2003 | CN1399573A Use of phthalazine derivatives |
| 02/26/2003 | CN1399565A Propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 02/26/2003 | CN1399559A Micro-cluster liquids and methods of making and using them |
| 02/26/2003 | CN1399552A Method and composition for treatment of adenoviral ocular infections |
| 02/26/2003 | CN1399539A Adjuvant comprising polyxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 02/26/2003 | CN1399516A Novel composition |
| 02/26/2003 | CN1398965A Type-O hoof-and-mouth disease virus, type-O hoof-and-mouth disease vaccine with the virus and active component and the prepn of the vaccine |
| 02/26/2003 | CN1398897A Serial synthetic antibacterial peptide |
| 02/26/2003 | CN1398854A New iso quinoline compound with HIV-1 resisting activity |
| 02/26/2003 | CN1398838A Diphenylethylene compound and its prepn and application in preventing and treating diabetes |
| 02/26/2003 | CN1398638A Preparation of tick-borne encephalitis resisting vaccine |
| 02/26/2003 | CN1398637A Thymosin alpha-1 microball prepn and its prepn process |
| 02/26/2003 | CN1398626A Yinhuang powder injection for intravenous injection and its prepn process |
| 02/26/2003 | CN1398619A Chinese medicine for treating osteonecrosis and osteomyelitis and its prepn |
| 02/26/2003 | CN1398616A Medicine for treating upper respiratory tract infection and its prepn |
| 02/26/2003 | CN1398610A Bupleurum-Puerariae granule and its prepn process |
| 02/26/2003 | CN1398602A Medicated tea |
| 02/26/2003 | CN1398598A Chinese medicine for treating tuberculosis |
| 02/26/2003 | CN1398597A Medicine for treatment of venereal disease |
| 02/26/2003 | CN1398596A External medicine for treating tinea |
| 02/26/2003 | CN1398594A Application of sodium bicarbonate in preparing medicine for hepatitis |
| 02/26/2003 | CN1398587A Slow-releasing Metronidazole prepn for position of colon |
| 02/26/2003 | CN1398582A Local acne treating device |
| 02/26/2003 | CN1102174C Ribozyme |
| 02/26/2003 | CN1102066C Medicine for treating AIDS and tumor and its preparing process |
| 02/26/2003 | CN1102048C Anticancer detoxicating pill and its preparing process |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525193 Aminoaryl oxazolidinone N-oxides |
| 02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6525102 Increasing storage stability of interleukin-2 by incorporating free base form arginine and succinic acid |
| 02/25/2003 | US6525071 Compositions and methods for the treatment and prevention of bovine mastitis |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/25/2003 | US6525066 4-oxoquinolizine antimicrobial having 2-pyridone skeleton as partial structure |
| 02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/25/2003 | US6525051 For treating cytokine-induced hypotension, inflammatory bowel disease, cerebral ischemia, arthritis, adult respiratory distress syndrome, asthma |
| 02/25/2003 | US6525049 Pyrroloquinolones as antiviral agents |
| 02/25/2003 | US6525040 4,4-dimethyl-thieno-(3,2-e)-isoselenazine; antioxidants and cytoprotecting |
| 02/25/2003 | US6525033 2', 3' dideoxynucleoside compounds; 2',3'-dideoxycytidine (beta -L-FddC), beta -L-2',3'-dideoxy-5-fluorocytidine (beta-L-ddC); beta-D-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-dioxolane |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/25/2003 | US6524825 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/25/2003 | US6524821 Anti-apoptotic compositions comprising the R1 subunit of herpes simplex virus ribonucleotide reductase or its N-terminal portion; and uses thereof |
| 02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
| 02/25/2003 | US6524625 Physiologically active extract obtained from indigo plant polygonum tinctorium |
| 02/25/2003 | US6524593 N-acetyl aldosamines and related N-acetyl compounds, and their topical use |
| 02/25/2003 | US6524585 Using the indolicidin analogs to reduce or inhibit microbial growth or survival by contacting an environment with the indolicidin analog |
| 02/25/2003 | US6524582 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6524576 Probiotic composition; veterinary feed additive; food additive; microorganisms dispenser; eliminating an oil pollution; restoring organic fumes degrading microorganism population in a biofilter |
| 02/25/2003 | US6524575 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 02/25/2003 | US6524570 Polyethylene glycol modified interferon therapy |
| 02/25/2003 | US6524556 Tricyclic compound dispersed in liquefied hydrofluoroalkane propellant; medium-chain fatty acid triglyceride as dispersant |
| 02/25/2003 | CA2113080C Topical composition containing penciclovir |
| 02/25/2003 | CA2099841C Expression of recombinant proteins in attenuated bacteria |
| 02/25/2003 | CA2048910C Antimicrobial peptides active against plant pathogens, their method of use and various screening methods pertaining thereto |
| 02/21/2003 | WO2002016328A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | WO2002016323A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2420208A1 Biphenyl derivatives and their use as integrin inhibitors |
| 02/21/2003 | CA2420205A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014728A1 Remedies for hepatitis c |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014316A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014192A1 Quaternary polyamidoamines, the production thereof, corresponding agents and the use thereof |
| 02/20/2003 | WO2003014153A2 Cellular virus receptors and methods of use. |
| 02/20/2003 | WO2003014147A1 Novel depsipeptides and process for preparing same |
| 02/20/2003 | WO2003014136A1 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME |
| 02/20/2003 | WO2003014105A1 Bicyclic compound, production and use as hiv inhibitors |